Alzheimer; News from the web:
What if we think of Alzheimer’s not as one disease, but three separate ones, with overlapping symptoms? Researchers behind a new study say Alzheimer’s encapsulates three distinct molecular conditions, and that a better understanding of each could be a lifeline for failed Alzheimer’s treatment efforts and future research.
Read all about it HERE
Alzheimer; News from the web:
Researchers have developed a method based on Artificial Intelligence (AI) that rapidly identifies currently available medications that may treat Alzheimer’s disease.
Read all about it HERE
Alzheimer; News from the web:
The gut microbiome has been seen to affect our overall health. From our immune system, to appetite and metabolism, our gut microbiota has many influences on our health. The microbiome is composed of bacteria, archaea, viruses, and eukaryotic microbes that reside in and on our bodies. These microbes have tremendous potential to impact our physiology, both in health and in disease. Each person has an entirely unique network of microbiota that is originally determined by one’s DNA. A person is first exposed to microorganisms as an infant, and later on, environmental exposures and diet can change one’s microbiome to be either beneficial to health or place one at greater risk for disease. New research demonstrates that changes to our gut microbiome can be linked to Alzheimer’s-like behavior.
https://www.genengnews.com/
Read all about it HERE
Alzheimer; News from the web:
Exercising regularly has many health benefits, but did you know aerobic exercise could also benefit older adults living with Alzheimer’s dementia?
https://www.timesnownews.com/
Read all about it HERE
Alzheimer; News from the web:
Black people are about twice as likely as White people to get the disease, and Latino residents are 1.5 times more likely to suffer from it than White people. Besides their higher risks, people of color face additional Alzheimer’s challenges: noted racial disparities in how the disease is detected and how research on it is done.
Read all about it HERE
Alzheimer; News from the web:
In 2018, a research group led by David Holtzman, M.D., at Washington University in St. Louis developed an antibody drug in collaboration with Denali Therapeutics that showed promise as a potential Alzheimer’s disease therapy. Now, the team has returned with mouse data suggesting the drug prospect might be a safer option than Biogen’s much-hyped aducanumab.
Read all about it HERE